Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure
- 1 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cardiovascular Drugs and Therapy
- Vol. 35 (5), 1009-1023
- https://doi.org/10.1007/s10557-020-07046-1
Abstract
Introduction Daily medication is the cornerstone of evidence-based therapy to reduce mortality and morbidity in patients with heart failure (HF). Up to 20% of Canadian patients pay for medications out of pocket. We sought to identify strategies that patients and prescribers can employ to reduce these costs. Methods We collected data from outpatient pharmacies in Hamilton, Ontario. We determined prices for different medications in each of the drug classes recommended for HF with reduced ejection fraction in the Canadian Cardiovascular Society's guidelines. We examined differences in dispensing and delivery fees and inquired about other cost-saving strategies. Results We collected data from 24 different pharmacies, including a selection of hospital-based, independent, and larger chain pharmacies. In the most extreme scenario (i.e., 90-day prescription instead of a 30-day prescription and the least expensive generic drug instead of the most expensive brand name drug), total medication costs can differ by up to $495.56 per month. Costs were affected by choice of agent within a drug class, generic versus brand-name drug, quantity dispensed, dispensing fee, and delivery cost. Conclusions Prescription content, dispensing practice, and pharmacy choice can remarkably impact out-of-pocket costs for HF medications. Prescribers can reduce costs by writing 90-day prescriptions and choosing the lowest-cost generic drugs in each therapeutic class. Patients should consider the services received for their pharmacy dispensing fees, use free delivery services where needed, and request inexpensive generic drugs. Pharmacists can facilitate cost minimization without compromising therapeutic efficacy.This publication has 15 references indexed in Scilit:
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- We need to mandate drug cost transparency on electronic medical recordsCMAJ : Canadian Medical Association Journal, 2017
- 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart FailureCanadian Journal of Cardiology, 2017
- Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countriesBMJ Open, 2017
- Universal prescription drug coverage in CanadaHealthcare Management Forum, 2016
- Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement PopulationJournal of General Internal Medicine, 2015
- Use of Prescription Drug Samples and Patient Assistance Programs, and the Role of Doctor–Patient CommunicationJournal of General Internal Medicine, 2011
- Medication Adherence in Cardiovascular DiseaseCirculation, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Physician Awareness of Drug Cost: A Systematic ReviewPLoS Medicine, 2007